Orphan drugs are pharmaceuticals developed to treat rare diseases or conditions that affect a relatively small number of individuals. As such, drug companies often develop and manufacture these medications in limited quantities to address a public health need rather than for economic benefit.
AllCare Plus is experienced and effective at managing high-cost medications that are unique to the specialty pharmacy industry. The small group of ultra-high-touch patients and their families that make up the orphan disease space requires individual counseling, which traditional specialty pharmacies are not equipped to handle. AllCare Plus’ unique team infrastructure allows our reimbursement and clinical staff to focus on chronic and orphan diseases while never compromising patient care.
Source: Orphanet, “What is an orphan drug?” http://www.orpha.net/consor/cgi-bin/Education_AboutOrphanDrugs.php?lng=EN.